1-3 of 3
Morten Schou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial

Emil Wolsk, Mikkel Jürgens, Morten Schou, Mads Ersbøll, Philip Hasbak, Andreas Kjær, Bo Zerahn, Niels Høgh Brandt, Peter Haulund Gæde, Peter Rossing, Jens Faber, Silvio E. Inzucchi, Caroline Michaela Kistorp, Finn Gustafsson
Journal: Diabetes
Diabetes 2022;71(4):812–820
https://doi.org/10.2337/db21-0721
Published: 21 January 2022
View article titled, Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial
Open the PDF for Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial in another window
Journal Articles

The Mineralocorticoid Receptor Antagonist Eplerenone Suppresses Interstitial Fibrosis in Subcutaneous Adipose Tissue in Patients With Type 2 Diabetes

Marie Louise Johansen, Jaime Ibarrola, Amaya Fernández-Celis, Morten Schou, Mette Pauli Sonne, Maria Refsgaard Holm, Jon Rasmussen, Flemming Dela, Frederic Jaisser, Jens Faber, Patrick Rossignol, Natalia Lopez-Andres, Caroline Kistorp
Journal: Diabetes
Diabetes 2021;70(1):196–203
https://doi.org/10.2337/db20-0394
Published: 14 October 2020
View article titled, The Mineralocorticoid Receptor Antagonist Eplerenone Suppresses Interstitial Fibrosis in Subcutaneous Adipose Tissue in Patients With Type 2 Diabetes
Open the PDF for The Mineralocorticoid Receptor Antagonist Eplerenone Suppresses Interstitial Fibrosis in Subcutaneous Adipose Tissue in Patients With Type 2 Diabetes in another window
Meeting Abstracts

1181-P: Effect and Feasibility of High Dose Eplerenone in Type 2 Diabetes: A Mirad Substudy

NIELS HØEG BRANDT-JACOBS, JON BJARKE RASMUSSEN, MARIE-LOUISE JOHANSEN, PATRICK ROSSIGNOL, JENS FABER, MORTEN SCHOU, CAROLINE MICHAELA KISTORP
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1181-P
https://doi.org/10.2337/db19-1181-P
Published: 01 June 2019
View article titled, 1181-P: Effect and Feasibility of High Dose Eplerenone in Type 2 Diabetes: A Mirad Substudy